Velsipity (etrasimod) is a medication that treats ulcerative colitis (UC) in adults. It works as a sphingosine 1-phosphate (S1P) receptor modulator to help relieve gut inflammation and symptoms of UC. The usual dose is 1 tablet by mouth once a day. Velsipity (etrasimod) can cause side effects like headache and dizziness. It also has a few serious risks, including infection, heart problems, and liver damage. Velsipity (etrasimod) is available as a brand-name medication.
Velsipity (etrasimod) is a sphingosine 1-phosphate (S1P) receptor modulator. It's not exactly clear how this medication works to treat UC.
Researchers think that Velsipity (etrasimod) lowers the number of white blood cells that get to your gut. This is thought to help lessen gut inflammation and relieve symptoms of UC.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
No, Velsipity (etrasimod) isn't a biologic. Biologics are made in the lab from living sources, like cells. And, they're usually given as injections. Instead, Velsipity (etrasimod) is called a small molecule drug. It's made in the lab from chemicals. This medication is a tablet that you take by mouth. Ask your prescriber if you have more questions about how Velsipity (etrasimod) is made.
Yes. Velsipity (etrasimod) was approved by the FDA in October 2023. It's approved for adults with moderate-to-severe ulcerative colitis.
Velsipity (etrasimod) has a risk of causing some side effects that affect the eyes. One example is macular edema. This is an eye problem caused by swelling in the macula (the part of the retina that helps you see clearly). Macular edema can make you have problems with yoruu vision. It can cause blurry vision, vision that gets worse over time, wavy vision, and dull color vision. Velsipity (etrasimod) also has a rare risk of serious brain problems that can make your eyes sensitive to light or cause changes in vision. If you notice any changes in your vision, tell your prescriber right away so they can check it out.
In a study, almost 1 out of every 3 people got to remission after 3 months of taking Velsipity (etrasimod). This was about the same after they took the medication for a whole year. In comparison, less than 1 out of every 10 people who took a placebo got to remission. Getting to remission means having little or no symptoms of ulcerative colitis (UC). In this study, people had already tried other medications for UC, like biologics. But those medications didn't help enough. If you have questions about how well Velsipity (etrasimod) might work for you, ask your prescriber.
In studies, some people had fewer symptoms of ulcerative colitis within the first 2 weeks of taking Velsipity (etrasimod). This included having to go to the bathroom less often and less rectal bleeding. But it can take a few months or longer to see the full effects of this medication. If you have questions about how long Velsipity (etrasimod) is taking to work for you, ask your prescriber.
Velsipity (etrasimod) and Zeposia (ozanimod) are medications that work in the same way. They can both help treat ulcerative colitis in adults. But Zeposia can also treat multiple sclerosis. The two medications are both pills that are taken by mouth once a day. But the dosing is a little different. For Velsipity, you take the same dose throughout the entire treatment. But for Zeposia, you start off at a lower dose and then your dose gets slowly raised over a week. Both medications can slow your heart rate at first, but Zeposia is approved with an initial dose ramp-up schedule to help with this side effect. Talk to your prescriber to compare the medications and see which is right for you.
No. Velsipity (etrasimod) isn't FDA approved to treat Crohn's disease. The CULTIVATE study was looking into using this medication to treat moderate-to-severe Crohn's disease in adults. But there wasn't enough evidence that it worked well for this gut problem. So, the study ended early. Talk to your prescriber to learn about your treatment options for Crohn's disease.
It depends. If you want to get a vaccine while taking Velsipity (etrasimod), talk to your prescriber or pharmacist. They can help you understand the risks and benefits of getting the vaccine you want. They can also tell you the best time to get it. It's not clear if Velsipity (etrasimod) can make some vaccines not work as well. If you need to get a live vaccine, get it at least 4 weeks before you start Velsipity (etrasimod). You can also wait at least 5 weeks after you finish treatment to get it. Examples of live vaccines include Varivax (varicella vaccine) and FluMist (nasal spray flu vaccine). But you might be able to get other kinds of vaccines, if your care team recommends them. This can include most flu shots and the COVID-19 vaccine.
Velsipity (etrasimod) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Velsipity (etrasimod) can lower your white blood cell (WBC) count. It can stay low while you're taking the medication and for up to 5 weeks after you stop. Before you start, your care team will check your WBC count with a blood test.
Having a low WBC count can make it easier to get an infection. Some infections can be serious. If you already have an infection, you'll need to get it treated before you can start Velsipity (etrasimod).
In studies with Velsipity (etrasimod), the most common infections were urinary tract infection (UTI) and herpes viral infections (like cold sores or shingles). If you think you have an infection, talk to your care team. You might need medication to treat it. You also might need to stop Velsipity (etrasimod) until you get better.
In rare cases, some people taking medications like Velsipity (etrasimod) have had serious brain infections. Examples include meningitis and progressive multifocal leukoencephalopathy (PML). Get medical help right away if you have signs like weakness on one side of your body, headache, stiff neck, nausea, changes in vision, and confusion. The medical team will check what's causing these symptoms.
Velsipity (etrasimod) can slow down your heart rate. This can happen after first starting the medication, but it usually goes away over time. Some people might not feel anything, but others might feel dizzy. Rarely, Velsipity (etrasimod) can also slow your heart rhythm.
Before starting Velsipity (etrasimod), tell your prescriber if you have any heart problems. This includes having a slow heartbeat when you're at rest or other problems with heart rhythm (arrhythmia). Your prescriber might order a test called an electrocardiogram (EKG) to check your heart.
Also, let your prescriber know if you take other medications that can affect your heartbeat. Examples include amiodarone (Pacerone) and atenolol (Tenormin). Your prescriber can check that Velsipity (etrasimod) is safe for you.
If you feel dizzy, lightheaded, short of breath, confused ,or have chest pain while taking Velsipity (etrasimod), call your care team right away. These can be signs of a slow heart rate or a slow heart rhythm.
Velsipity (etrasimod) can raise your blood pressure. In studies, blood pressure went up by a little (an average of 1 mmHg to 4 mmHg). This change in blood pressure started 2 weeks after beginning treatment.
Your healthcare team might ask you to check your blood pressure at home while you're taking Velsipity (etrasimod). Tell them if it stays higher than usual.
Some people who take Velsipity (etrasimod) can have higher liver enzyme levels on their lab tests. This can be a sign that the liver is irritated. Before you start Velsipity (etrasimod), you'll need to get a blood test. This helps your prescriber check your liver and decide if the medication is safe to take.
While you're taking Velsipity (etrasimod), watch for any pain in the upper right side of your stomach, yellow skin or whites of your eyes, or dark urine. These could be signs of liver problems. If this happens, let your care team know. You'll need a blood test to make sure your liver is okay.
Velsipity (etrasimod) can raise your risk of an eye condition called macular edema. This eye problem happens when a part of the retina called the macula swells. It can cause blurry vision and, over time, possibly vision loss.
Your prescriber will refer you to an eye specialist before you start Velsipity (etrasimod). You'll get an eye exam to check your vision. You'll also need eye exams from time to time during treatment.
Let your care team know right away if you have any blurry or wavy vision or see things in dull color. They'll have you get an eye exam to check for macular edema. If you have macular edema, you might need to stop taking Velsipity (etrasimod).
Animal studies show that Velsipity (etrasimod) might harm an unborn baby when taken during pregnancy. If you can get pregnant, use birth control while taking this medication. Continue to use birth control and try not to get pregnant for one week after your last dose. If you become pregnant or think you might be, tell your healthcare team right away.
Some people have gotten skin cancer after taking medications like Velsipity (etrasimod). Phototherapy or light therapy isn't recommended for people taking Velsipity (etrasimod) because of the risk of skin cancer.
Your care team will check your skin every so often while you're taking Velsipity (etrasimod). They can help check for any unusual changes in your skin. They might check your skin more often if you're more at risk for skin cancer. This includes having light skin, skin that burns easily, or a personal or family history of skin cancer.
To help protect yourself, stay out of direct sunlight as much as possible. Wear protective clothing and use sunscreen. Tell your care team if you see a new spot on your skin, a sore that doesn’t heal, or any unusual changes in your skin. They might refer you to a dermatologist to check it out.
Although rare, some people taking medications like Velsipity (etrasimod) have had a brain problem called posterior reversible encephalopathy syndrome (PRES). This problem can cause swelling in the brain and can be serious. Sometimes, it can lead to a stroke.
Get medical help right away if you have signs of PRES. Look out for dull headaches that get worse, strange behavior, vision changes, confusion, or seizures. Your care team will run tests to see what might be going on. If they think you have PRES, they'll tell you to stop taking Velsipity (etrasimod).
Some people who took Velsipity (etrasimod) had breathing problems. This can happen as early as 3 months after you start the medication.
Before starting Velsipity (etrasimod), tell your healthcare team if you have lung problems. This includes asthma and chronic obstructive pulmonary disease (COPD). Your care team might check your lungs regularly during treatment. Make sure you have a rescue inhaler like albuterol (Ventolin) to use if you have trouble breathing.
Let your healthcare team know if you feel short of breath or have any breathing problems while taking Velsipity (etrasimod). They can help see what's going on.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 2mg | 30 tablets | $6,436.83 | $214.56 |
The typical dose is 2 mg by mouth once a day.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Velsipity (etrasimod) will not be safe for you to take.